Background: Fecal incontinence is defined as involuntary passage of stool through the anus. It may vary from soiling to complete evacuation. This involuntary loss of feces, flatus or urge incontinence adversely affects quality of life. Urinary urge incontinence is characterized by symptoms of frequency, urgency and urge incontinence (either alone or in combination). Urgency frequency syndrome is defined as symptoms of frequency and urgency without incontinence episodes.
Objectives: To evaluate the efficacy of sacral neuromodulation on these pathologies
Methods: Following a detailed investigation, 51 patients with either urinary or fecal incontinence, or both, who did not respond
to medicaland behavioral treatment were offered the temporary implant. Of the 51 patients 40 showed improvement and advanced for a permanent device.
Results: After a mean follow-up of 5 years (range 1-8), there was a significant reduction in the number of incontinence episodes (P < 0.0001), and the number of pads used also declined significantly (P < 0.0001). A marked improvement in quality of life was reported by 71.4% of the women and 58.3% of the men.
Conclusions: Sacral neuromodulation as shown in this study appears to be a promising treatment for urinary and fecal incontinence and can dramatically improve patients‘ quality of life.